AU Patent

AU2012203219A1 — Induction of arteriogenesis

Assigned to G Pohl Boskamp GmbH and Co KG · Expires 2013-12-19 · 12y expired

What this patent protects

Abstract The present invention inter alia relates to a method of promoting collateral circulation comprising the step of exposing a subject to a therapeutically effective amount of an NO 5 donor wherein the therapeutically effective amount of the NO donor promotes arteriogenesis …

USPTO Abstract

Abstract The present invention inter alia relates to a method of promoting collateral circulation comprising the step of exposing a subject to a therapeutically effective amount of an NO 5 donor wherein the therapeutically effective amount of the NO donor promotes arteriogenesis sufficient to augment collateral circulation in a physiological or pathological condition.

Drugs covered by this patent

Patent Metadata

Patent number
AU2012203219A1
Jurisdiction
AU
Classification
—
Expires
2013-12-19
Drug substance claim
No
Drug product claim
No
Assignee
G Pohl Boskamp GmbH and Co KG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.